Single‐centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell‐associated neurotoxicity in patients receiving axicabtagene ciloleucel

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Figure S1. Figure S2. Table S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.